Case Report: Intravenous and Oral Pyridoxine Trial for Diagnosis of Pyridoxine-Dependent Epilepsy
- 1 July 2015
- journal article
- case report
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 136 (1) , e257-e261
Abstract
Pyridoxine-dependent epilepsy is a rare, autosomal recessive, treatable cause of neonatal seizures. Genetic testing can confirm mutations in the ALDH7A1 gene, which encodes antiquitin. To avoid delays in initiating treatment while awaiting confirmatory genetic testing, it is recommended that all neonates with unexplained seizures should receive trial of intravenous (IV) pyridoxine to assess for responsiveness. However, oral pyridoxine is not commonly continued in the absence of the typical EEG changes. Two cases are presented that highlight the potential inadequacy of this single-step approach. One neonate ultimately diagnosed with pyridoxine-dependent seizures had no EEG changes after administration of IV pyridoxine. In contrast, another neonate who did not have this diagnosis had profound EEG changes after pyridoxine administration. We present 2 cases that highlight the difficulties in using initial EEG response to IV pyridoxine in establishing a diagnosis of pyridoxine-dependent seizures in the neonate. Given the availability of biochemical markers and gene testing, we suggest that oral pyridoxine treatment should be continued until biochemical and/or genetic testing has confirmed the presence or absence of pyridoxine-dependent epilepsy.Keywords
This publication has 18 references indexed in Scilit:
- Profound Neonatal Hypoglycemia and Lactic Acidosis Caused by Pyridoxine-Dependent EpilepsyPediatrics, 2012
- Urinary AASA excretion is elevated in patients with molybdenum cofactor deficiency and isolated sulphite oxidase deficiencyJournal of Inherited Metabolic Disease, 2012
- The EEG response to pyridoxine‐IV neither identifies nor excludes pyridoxine‐dependent epilepsyEpilepsia, 2010
- The genotypic and phenotypic spectrum of pyridoxine‐dependent epilepsy due to mutations in ALDH7A1Journal of Inherited Metabolic Disease, 2010
- Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine‐dependent epilepsy and pyridoxine phosphate oxidase deficiencyDevelopmental Medicine & Child Neurology, 2010
- Folinic acid–responsive seizures are identical to pyridoxine‐dependent epilepsyAnnals of Neurology, 2009
- The Pediatric Neurotransmitter DisordersJournal of Child Neurology, 2007
- Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) geneHuman Mutation, 2006
- Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatmentCurrent Opinion in Neurology, 2006
- Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disordersMolecular Genetics and Metabolism, 2004